









Markets
/
Stocks
/
nasdaq-tmo
/

Thermo Fisher Scientific Inc

TMO



View Detailed Chart

474.460USD

-5.000-1.04%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

179.16BMarket Cap

27.21P/E TTM



Thermo Fisher Scientific Inc

474.460

-5.000-1.04%

Overview Company Financials Analysis

Analysis

Intraday

30m

Today

-1.04%

5 Days

-2.70%

1 Month

-2.98%

6 Months

-9.12%

Year to Date

-8.80%

1 Year

-22.37%

View Detailed Chart

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

29 / 207

Overall Ranking

125 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 31 analysts

Buy

Current Rating

555.814

Target Price

+15.92%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.

Undervalued

The company’s latest PE is 27.39, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 351.93M shares, decreasing 1.24% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 33.62M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.04.

News

Thermo Fisher Scientific To Acquire Solventum’S Purification And Filtration Business

Feb 25 (Reuters) - Thermo Fisher Scientific Inc TMO.N:THERMO FISHER SCIENTIFIC TO ACQUIRE SOLVENTUM’S PURIFICATION AND FILTRATION BUSINESSTHERMO FISHER SCIENTIFIC INC - TO ACQUIRE SOLVENTUM'S PURIFICATION & FILTRATION BUSINESS FOR $4.1 BILLIONTHERMO FISHER SCIENTIFIC INC - TRANSACTION EXPECT...

ReutersTue, Feb 25

Thermo Fisher Scientific Inc reports results for the quarter ended December 31 - Earnings Summary

Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $6.10 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $5.67. The mean expectation of twenty five analysts for the quarter was for earnings of $5.94...

ReutersThu, Jan 30